Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report.

Taimur Sher, Kena C. Miller, Kelvin Lee, Asher Chanan-Khan

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Multiple myeloma patients with plasmablastic morphology of tumor cells and extramedullary presentation of disease often have an aggressive clinical course and resistance to chemotherapy. We describe a case of an elderly patient who presented with extramedullary, IgA-lambda-secreting multiple myeloma with plasmablastic features who demonstrated impressive clinical response to single-agent lenalidomide. This is the first description of a plasmablastic variety of multiple myeloma successfully treated with lenalidomide alone.

Original languageEnglish (US)
Pages (from-to)328-330
Number of pages3
JournalClinical lymphoma & myeloma
Volume9
Issue number4
DOIs
StatePublished - Aug 2009

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report.'. Together they form a unique fingerprint.

Cite this